Drug intelligence / Profile preview

HBV vaccine + aqueous cream

Development stage
Unknown
Lead developer
Merck
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Topical
01

Overview

HBV vaccine + aqueous cream is a control intervention used in clinical research, specifically in trial NCT02621112. In this study, aqueous cream serves as a topical placebo pretreatment applied to the skin five minutes prior to the intramuscular injection of a hepatitis B virus (HBV) vaccine. The combination was designed to maintain blinding in studies evaluating the efficacy of topical immunomodulators, such as imiquimod, as adjuvants to improve the immunogenicity of HBV vaccination in populations with poor vaccine response, such as patients with end-stage renal disease on dialysis. The aqueous cream itself is an inert emollient with no active pharmaceutical ingredients, while the HBV vaccine is a standard prophylactic agent containing recombinant hepatitis B surface antigen (HBsAg).

Other names
hepatitis B vaccine + aqueous cream
02

Targets

HBsAg (Hepatitis B surface antigen)

Beyond the preview

Go deeper on HBV vaccine + aqueous cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HBV vaccine + aqueous cream.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call